Clinical trials recruiting for Adenoid Cystic Carcinoma
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Emi-Le | 1 |
| NN3201 | 1 |
| Nivolumab | 1 |
| RGT-61159 | 1 |
| VMD-928 100 mg Tablet | 1 |
| VMD-928 Tablet and Pembrolizumab (200 mg) | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Texas | 4 |
| Michigan | 3 |
| New York | 3 |
| Virginia | 3 |
| California | 2 |
| Florida | 2 |
| Massachusetts | 2 |
| Ohio | 2 |
| Utah | 2 |
| Washington | 2 |
| Arizona | 1 |
| Connecticut | 1 |
Top cities
Self-screener
Recruiting trials
- A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
- A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
- Agnostic Therapy in Rare Solid Tumors
- Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC)
- VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Related conditions
Trials recruiting for Adenoid Cystic Carcinoma often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Adenoid Cystic Carcinoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.